The latest closing stock price for Neumora Therapeutics as of June 26, 2025 is 0.80.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-953 today, roughly -1 times their original investment - a -78.32% compound annual growth rate over 2 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 17.19, which is 2048.8% above the current share price.
The Neumora Therapeutics 52-week low stock price is 0.61, which is 23.8% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 6.70.
An investor who bought $1,000 worth of Neumora Therapeutics stock at the IPO in 2023 would have $-953 today, roughly -1 times their original investment - a -78.32% compound annual growth rate over 2 years.
The all-time high Neumora Therapeutics stock closing price was 19.76 on February 16, 2024.
The Neumora Therapeutics 52-week high stock price is 17.19, which is 2048.8% above the current share price.
The Neumora Therapeutics 52-week low stock price is 0.61, which is 23.8% below the current share price.
The average Neumora Therapeutics stock price for the last 52 weeks is 6.70.